Hypothesis

Early tau accumulation in the entorhinal cortex (EC) impairs grid‑cell mediated thalamic gating of ascending nociceptive signals, weakening descending noradrenergic inhibition from the locus coeruleus (LC). This disinhibition lowers thermal pain thresholds and raises unpleasantness, producing a pain‑sensitivity signature that tracks neurobiological age better than current epigenetic clocks.

Mechanistic Basis

1. EC grid cells provide spatial context to thalamic nuclei that relay pain signals to the somatosensory cortex; tau‑induced silencing of these cells disrupts contextual filtering, amplifying raw nociceptive flow 5.
2. Loss of EC output reduces excitatory drive to the LC‑noradrenergic system, which normally suppresses spinal dorsal horn activity via α2‑adrenergic receptors 6.
3. Consequently, thermal pain thresholds drop (as seen in aging 2) while sustained heat tolerance declines 3, mirroring the paradoxical pain phenotype linked to APOE4 and AD risk 4.
4. Chronic low‑grade inflammation and mitochondrial dysfunction, hallmarks of biological age 1, further exacerbate EC tau spread, creating a feed‑forward loop.

Testable Predictions

• In cognitively normal older adults, higher EC tau PET signal will predict lower thermal pain thresholds and higher unpleasantness ratings, independent of chronological age.
• Pharmacological LC activation (e.g., with atomoxetine) will normalize pain sensitivity in high‑EC‑tau individuals, whereas placebo will not.
• Longitudinally, increases in EC tau will precede measurable acceleration in epigenetic age clocks (e.g., GrimAge) by ≥12 months.
• Combining EC tau PET, thermal pain testing, and vagal‑tone indices will improve prediction of biological age (measured by multi‑omics age) beyond epigenetic clocks alone (ΔR² > 0.08).

Falsifiability

If EC tau burden shows no correlation with thermal pain metrics after controlling for inflammation and vascular burden, or if LC agonism fails to alter pain sensitivity in high‑tau subjects, the hypothesis is refuted.

Implications

A brief, non‑invasive pain‑sensitivity battery could serve as a functional read‑out of entorhinal network integrity, offering a low‑cost proxy for neurobiological aging where blood‑based markers fall short.